Morning News Run
Skin Cell Research Derails Stem Cell Debate - NPR (Audio)
The embryonic stem cell debate may be a thing of the past. At Whitehead Institute in Boston, researchers have succeeded in modifying a skin cell so that it behaves like an embryonic stem cell. And at Harvard University, scientists have shown that it’s possible to make clone mice from previously fertilized eggs.
US scientists discover new, potentially deadly bacteria - Breitbart.com
In a dramatic case of microbial sleuthing, US scientists said they have discovered a new, potentially deadly strain of bacteria previously unknown to medicine. The bacteria was found in a 43-year-old American woman who had traveled across Peru for three weeks and suffered from symptoms similar to typhoid fever or malaria. The woman has since recovered.
High Self-esteem May Be Culturally Universal, International Study Shows - Science Daily
The notion that East Asians, Japanese in particular, are self-effacing and have low self-esteem compared to Americans may well describe the surface view of East Asian personality, but misses the picture revealed by recently developed measures of self-esteem, according to a new study by a team of researchers from the United States, China and Japan.
Meningitis jab to halt outbreaks - BBC
A new meningitis vaccine could end devastating epidemics in hotspots like India and Africa, work suggests. The new vaccine protects against meningitis A, the deadliest form of the disease.
Scientists Apply for First Patent on Synthetic Life Form - WIRED
Scientists at the J. Craig Venter Institute have applied for a U.S. patent on a minimal bacterial genome that they built themselves. According to the patent application, it’s “a minimal set of protein-coding genes which provides the information required for replication of a free-living organism in a rich bacterial culture medium.”
Related Stories
POSTED IN: Morning News
0 opinions for Morning News Run
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: